Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of RP101 ophthalmic solution in post-menopausal women with moderate to severe dry eye syndrome
2017-005160-18Phase 2Completed
- Sponsor
- Redwood Pharma
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brivudine in dry eye syndrome (DED), sponsored by Redwood Pharma. Started Jun 2018; status: completed.
02
Drugs
brivudine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2017-005160-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005160-18.